S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/RTW Investments/Q2 2021

RTW Investments

Period: Q2 2021 Β· Filed: 2021-08-13
View on SEC EDGAR β†—
AUM
$6.63B
Total portfolio value
Positions
113
Reported securities
Top Holding
RCKT
10.0% $663.9M
QoQ Changes
+8 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2021-08-13) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
RCKTROCKET PHARMACEUTICALS INC$663.9M10.02%$44.29$3.84-91.3%
10.0%
SPYSPDR S&P 500 ETF TR$426.5M6.44%$400.08$744.78+86.2%
6.4%
ALNYALNYLAM PHARMACEUTICALS INC$285.4M4.31%$169.52$312.78+84.5%
4.3%
DRNADICERNA PHARMACEUTICALS INC$280.7M4.24%β€”β€”
4.2%
VCELVERICEL CORP$237.2M3.58%$52.50$46.98-10.5%
3.6%
MRTXMIRATI THERAPEUTICS INC$235.4M3.55%β€”β€”
3.5%
ILMNILLUMINA INC$228.5M3.45%$460.32$188.68-59.0%
3.5%
PTCTPTC THERAPEUTICS INC$223.8M3.38%$42.27$83.31+97.1%
3.4%
ESTAESTABLISHMENT LABS HLDGS INC$202.6M3.06%$87.34$89.25+2.2%
3.1%
MASIMASIMO CORP$200.3M3.02%$242.45β€”
3.0%
NTRANATERA INC$194.4M2.93%$113.53$279.32+146.0%
2.9%
PTGXPROTAGONIST THERAPEUTICS INC$157.4M2.38%$44.88$131.62+193.3%
2.4%
TXG10X GENOMICS INC$143.8M2.17%$195.82$39.01-80.1%
2.2%
CLDXCELLDEX THERAPEUTICS INC NEW$130.7M1.97%$33.44$38.37+14.7%
2.0%
DMTKQDERMTECH INC$129.6M1.96%β€”β€”
2.0%
GMEDGLOBUS MED INC$129.5M1.95%$77.53$80.12+3.3%
1.9%
AXNXAXONICS INC$123.3M1.86%β€”β€”
1.9%
STOKSTOKE THERAPEUTICS INC$122.7M1.85%$33.66$32.70-2.9%
1.9%
GHGUARDANT HEALTH INC$114.0M1.72%$124.19$167.98+35.3%
1.7%
QDELXXXXQUIDEL CORP$112.6M1.70%β€”β€”
1.7%
TNDMTANDEM DIABETES CARE INC$111.8M1.69%$97.40$15.32-84.3%
1.7%
AXSMAXSOME THERAPEUTICS INC$109.0M1.65%$67.46$244.31+262.2%
1.6%
RNAMAVIDITY BIOSCIENCES INC$98.7M1.49%β€”β€”
1.5%
EPIXESSA PHARMA INC$87.3M1.32%β€”β€”
1.3%
CCCCC4 THERAPEUTICS INC$81.3M1.23%$37.84$4.30-88.6%
1.2%
RXDXPROMETHEUS BIOSCIENCES INC$76.0M1.15%β€”β€”
1.1%
IDYAIDEAYA BIOSCIENCES INC$68.6M1.03%$20.99$37.65+79.4%
1.0%
MGNXMACROGENICS INC$68.4M1.03%$26.86$4.71-82.5%
1.0%
RGNXREGENXBIO INC$68.3M1.03%$38.85$13.28-65.8%
1.0%
AGENAGENUS INC$62.8M0.95%$107.75$3.49-96.8%
0.9%

Quarter-on-Quarter Activity

Q2 2021 vs. Q1 2021

New Positions (8)

TickerIssuerNotional
GHRSGH RESEARCH PLC$42.7M
CUTRQCUTERA INC$35.3M
GLUEMONTE ROSA THERAPEUTICS INC$25.2M
NEONEOGENOMICS INC$13.1M
BMEABIOMEA FUSION INC$12.3M
NAUTNAUTILUS BIOTECHNOLOGY INC$10.4M
SMIHUSUMMIT HEALTHCRE ACQUISTN CO$5.0M
TBIOCODEX DNA INC$4.4M

Exited Positions (8)

TickerIssuerNotional
CERNCerner Corp$127.5M
ARVNArvinas Inc$107.3M
IMVTImmunovant Inc$102.0M
TBIOTranslate Bio Inc$72.3M
CRISCuris Inc$41.0M
KURAKura Oncology Inc$30.6M
ARYAArya Sciences Acquisition Co$6.9M
NUVBNuvation Bio Inc$3.1M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
EPIXESSA PHARMA INC$79.0M+976.5%
OLKOLINK HLDG AB$36.3M+571.7%
RGNXREGENXBIO INC$54.1M+321.9%-65.8%
GHGUARDANT HEALTH INC$21.0M+50.6%+35.3%
VINCVINCERX PHARMA INC$0.1M+50.0%
LSAQLIFESCI ACQUISITION II CORP$3.2M+50.0%
MASIMASIMO CORP$63.7M+38.9%
IDYAIDEAYA BIOSCIENCES INC$10.6M+32.4%+79.4%

Trimmed (8)

TickerIssuerNotionalShares Ξ”Since Filing
XGNEXAGEN INC$-16.1M-49.5%
ITOSITEOS THERAPEUTICS INC$-50.4M-37.9%
ATHAATHIRA PHARMA INC$-29.3M-28.1%
TARSTARSUS PHARMACEUTICALS INC$-20.7M-18.3%
AGENAGENUS INC$25.3M-17.0%-96.8%
BOLTBOLT BIOTHERAPEUTICS INC$-3.0M-15.8%
CTMXCYTOMX THERAPEUTICS INC$-3.0M-8.7%
RCKTROCKET PHARMACEUTICALS INC$-33.4M-4.6%-91.3%
← Back to Hedge Funds